Spark Therapeutics (ONCE) Boosts Expected IPO Price Range

Spark Therapeutics (NASDAQ: ONCE) filed an amended registration with the U.S. SEC for an IPO of its common stock. The company plans to sell 6.5 million shares and sees an offering price of $19 - $21 per share, from a prior range of $15 - $17 per share. The company has applied to list its shares on NASDAQ Global Market under the symbol "ONCE."

J.P. Morgan and Credit Suisse are the book-running managers. Cowen and Company and Sanford C. Bernstein are co-managers.

Spark Therapeutics is a leader in the field of gene therapy, seeking to transform the lives of patients suffering from debilitating genetic diseases by developing one-time, life-altering treatments.

You May Also Be Interested In

• YY Group Holding (YYGH) Closes $5M IPO
• Scilex Holding (SCLX) Prices 15M Share Offering at $1/sh
• HOOKIPA Pharma Inc. (HOOK) Announces Pivotal Phase 2/3 Trial Design for HB-200 plus Pembrolizumab